It has the human GM-CSF gene inserted into its genome and has shown durable anti-tumor activity in melanoma and soft tissue sarcoma [140,141], especially for patients who have progressed on anti-PD-1 therapy. This evidence concerns the gene CSF2 and neoplasm.